# Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension

> **NCT00820352** · PHASE3 · COMPLETED · sponsor: **University Teaching Hospital Hall in Tirol** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure, Diastolic
- Hypertension, Pulmonary

## Interventions

- **DRUG:** bosentan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00820352
- **Lead sponsor:** University Teaching Hospital Hall in Tirol
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820352, "Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00820352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*